#274: Regulatory Policy Roundtable: Pharmaceutical Quality, Generics, Innovative Medicines
Tuesday, June 18, 2024 3:15 PM to 4:15 PM · 1 hr. (US/Pacific)
Room 6C
09: Regulatory10: RegCMC-Product Quality
Information
Industry leaders will discuss how regulatory and industrial policy can support delivering quality-assured medicines to patients faster, how to assure pharmaceutical quality for innovative and generic medicines especially in light of new analytical technologies, and how to evaluate potential threats to quality in the context of benefit-risk and patient access.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Regulator Perspectives
Speakers

Katherine Wilson
Head, Global Regulatory Policy and IntelligenceViatris
Kristin Willemsen
Vice President, Scientific and Regulatory AffairsCanadian Generic Pharmaceutical Association
Brett Howard
Senior Director, US Regulatory PolicyUSP
Aaron Josephson
Senior Director, Global Regulatory PolicyTeva Pharmaceuticals
